To understand why AOM/DSS treatment resulted in differential phenotypic outcomes in an APP mutant background at the molecular level, we conducted RNA-seq using colon cancer tissues, adjacent normal colon tissues, or normal colon tissues when tumors were not formed. This evidence concerns the gene APP and colonic neoplasm.